Background Treatment with low-molecular-weight heparin (LMWH) favorably alters the vein
wall response to deep venous thrombosis (DVT), although the mechanisms remain unclear …

Introduction Patients with lower‐leg cast immobilization and patients undergoing knee
arthroscopy have an increased risk of venous thrombosis (VT). Guidelines are ambiguous …

Resolution of deep venous thrombosis involves coordinated inflammatory processes. T cells
regulate inflammation in vivo and modulate vascular remodeling in other settings, but their …

Background Post-thrombotic syndrome (PTS) is the most common complication of deep vein
thrombosis (DVT), but few data are available on the risk factors for PTS. Aims To assess …

Background Recent studies have suggested that catheter-directed thrombolysis (CDT)
reduces development of post-thrombotic syndrome (PTS). Ultrasound-assisted CDT …

Background This randomised controlled trial investigates the dosing effect of neuromuscular
electrical stimulation (NMES) in patients with chronic venous disease (CVD). Methods …

Pharmacomechanical Thrombectomy (PMT) is recognized as a recent advancement in the
treatment of lower extremity deep venous thrombosis (DVT). Evidence for the use of this …

Background: Chronic kidney disease (CKD) has been implicated as a risk factor for venous
thromboembolism, but the evidence is limited to relatively healthy populations. The objective …

Background: The optimal duration of anticoagulation therapy (AT) following catheter-based
therapy of acute iliofemoral deep vein thrombosis (IFDVT) with stent placement is unknown …

Deep venous thrombosis (DVT) is common and can be a source of morbidity by way of
pulmonary embolism and post-thrombotic syndrome. Recent trials have demonstrated both …